Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Annual Review of Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1146/ANNUREV.BI.64.070195.003253PMID 7574497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The electrostatic basis for the interfacial binding of secretory phospholipases A2.

  1994cited by this paper
• Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.

  1994cited by this paper
• Structure and catalytic mechanism of secretory phospholipases A2.

  1994cited by this paper
• Inhibition of phospholipase A2

  1994cited by this paper
• The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

  1994cited by this paper
• Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2.

  1994cited by this paper
• Phosphatidylinositol-specific phospholipase C from Bacillus cereus at the lipid-water interface: interfacial binding, catalysis, and activation.

  1994cited by this paper
• A phospholipase A2 inhibitor from the plasma of the South American rattlesnake (Crotalus durissus terrificus). Protein structure, genomic structure, and mechanism of action.

  1994cited by this paper
• Diversity of group types, regulation, and function of phospholipase A2.

  1994cited by this paper
• Thielocin B3, a novel antiinflammatory human group II phospholipase A2 specific inhibitor from ascomycetes.

  1994cited by this paper
• Molecular cloning of pancreatic group I phospholipase A2 receptor.

  1994cited by this paper
• Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure.

  1994cited by this paper
• Cloning and expression of a membrane receptor for secretory phospholipases A2.

  1994cited by this paper
• Rational modification of human synovial fluid phospholipase A2 inhibitors.

  1994cited by this paper
• Isolation and amino acid sequence of a phospholipase A2 inhibitor from the blood plasma of Agkistrodon blomhoffii siniticus.

  1993cited by this paper
• Crystal structure of phospholipase A2 from Indian cobra reveals a trimeric association.

  1993cited by this paper
• Phospholipase A2 engineering. X-ray structural and functional evidence for the interaction of lysine-56 with substrates.

  1993cited by this paper
• Phospholipase A2 enzymes: regulation and inhibition.

  1993cited by this paper
• The chemical step is not rate-limiting during the hydrolysis by phospholipase A2 of mixed micelles of phospholipid and detergent.

  1993cited by this paper
• Competitive inhibition of lipolytic enzymes. IX. A comparative study on the inhibition of pancreatic phospholipases A2 from different sources by (R)-2-acylamino phospholipid analogues.

  1993cited by this paper
• Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome.

  1993cited by this paper
• Processive interfacial catalysis by mammalian 85-kilodalton phospholipase A2 enzymes on product-containing vesicles: application to the determination of substrate preferences.

  1993cited by this paper
• Spectroscopic properties of the states of pig pancreatic phospholipase A2 at interfaces and their possible molecular origin.

  1993cited by this paper
• Triggering of degranulation in mast cells by exogenous type II phospholipase A2.

  1993cited by this paper
• [Inhibitors of phospholipase A2].

  1993cited by this paper
• New insights on mammalian phospholipase A2(s); comparison of arachidonoyl‐selective and ‐nonselective enzymes

  1993cited by this paper
• The divalent cation is obligatory for the binding of ligands to the catalytic site of secreted phospholipase A2.

  1993cited by this paper
• Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.

  1993cited by this paper
• Polymerizable phosphatidylcholines: importance of phospholipid motions for optimum phospholipase A2 and C activity.

  1993cited by this paper
• Distributions of proteins and lipids in the erythrocyte membrane.

  1993cited by this paper
• Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.

  1993cited by this paper
• Acylation of porcine pancreatic phospholipase A2 influences penetration and substrate head-group binding, depending on the position of the acylated lysine in the enzyme molecule.

  1993cited by this paper
• Mammalian non-pancreatic phospholipases A2.

  1993cited by this paper
• Human nonpancreatic secreted phospholipase A2: interfacial parameters, substrate specificities, and competitive inhibitors.

  1993cited by this paper
• Phase separated anionic domains in ternary mixed lipid monolayers at the air-water interface.

  1993cited by this paper
• Recombinant human synovial fluid phospholipase A2 and N-terminal variant: kinetic parameters and response to inhibitors.

  1993cited by this paper
• N-(carboxymethyl)-N-[3,5-bis(decyloxy)-phenyl]glycine (Ro 23-9358): a potent inhibitor of secretory phospholipases A2 with antiinflammatory activity.

  1993cited by this paper
• Relationship of interfacial equilibria to interfacial activation of phospholipase A2.

  1993cited by this paper
• Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states.

  1993cited by this paper
• Substrate requirements of bacterial phosphatidylinositol-specific phospholipase C.

  1993cited by this paper
• Phospholipase A2 and arthritis.

  1993cited by this paper
• Crystallographic and biochemical studies of the (inactive) Lys-49 phospholipase A2 from the venom of Agkistridon piscivorus piscivorus.

  1992cited by this paper
• A novel type of phospholipase A2 inhibitor, thielocin A1 beta, and mechanism of action.

  1992cited by this paper
• Detection of three distinct phospholipases A2 in cultured mast cells.

  1992cited by this paper
• Basis for the anomalous effect of competitive inhibitors on the kinetics of hydrolysis of short-chain phosphatidylcholines by phospholipase A2.

  1992cited by this paper
• Phospholipase A2 inhibition by alkylbenzoylacrylic acids.

  1992cited by this paper
• Site-directed mutagenesis and X-ray crystallography of two phospholipase A2 mutants: Y52F and Y73F.

  1992cited by this paper
• Conformational changes in phospholipase A2 upon binding to micellar interfaces in the absence and presence of competitive inhibitors. A 1H and 15N NMR study.

  1992cited by this paper
• Phospholipase A2 engineering. Structural and functional roles of highly conserved active site residues tyrosine-52 and tyrosine-73.

  1992cited by this paper
• Regulation of Extracellular Phospholipase A2 Activity: Implications for Inflammatory Diseases

  1992cited by this paper
• Interfacial catalysis by phospholipase A2: the rate-limiting step for enzymatic turnover.

  1992cited by this paper
• Extracellular phospholipase A2.

  1992cited by this paper
• Isotope effects on enzyme-catalyzed reactions

  1992cited by this paper
• Phosphoinositide-specific phospholipase C-delta 1 binds with high affinity to phospholipid vesicles containing phosphatidylinositol 4,5-bisphosphate.

  1992cited by this paper
• Phospholipase A2 and signal transduction.

  1992cited by this paper
• Membrane structure, toxins and phospholipase A2 activity.

  1992cited by this paper
• Fatty acid amides: scooting mode-based discovery of tight-binding competitive inhibitors of secreted phospholipases A2.

  1992cited by this paper
• Molecular details of the activation of soluble phospholipase A2 on lipid bilayers. Comparison of computer simulations with experimental results.

  1992cited by this paper
• Substrate specificities and properties of human phospholipases A2 in a mixed vesicle model.

  1992cited by this paper
• Spontaneous domain formation of phospholipase A2 at interfaces: fluorescence microscopy of the interaction of phospholipase A2 with mixed monolayers of lecithin, lysolecithin and fatty acid.

  1992cited by this paper
• Reversibility of the activation of soluble phospholipase A2 on lipid bilayers: implications for the activation mechanism.

  1992cited by this paper
• Phospholipase A2 engineering. The structural and functional roles of aromaticity and hydrophobicity in the conserved phenylalanine-22 and phenylalanine-106 aromatic sandwich.

  1992cited by this paper
• The importance of glycine-30 for enzymatic activity of phospholipase A2.

  1991cited by this paper
• Interfacial catalysis by phospholipase A2: evaluation of the interfacial rate constants by steady-state isotope effect studies.

  1991cited by this paper
• Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants.

  1991cited by this paper
• Porcine pancreatic phospholipase A2: sequence-specific 1H and 15N NMR assignments and secondary structure.

  1991cited by this paper
• Kinetic characterization of phospholipase A2 modified by manoalogue.

  1991cited by this paper
• Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution

  1991cited by this paper
• Interfacial catalysis by phospholipase A2: activation by substrate replenishment.

  1991cited by this paper
• Interfacial catalysis by phospholipase A2: substrate specificity in vesicles.

  1991cited by this paper
• Phospholipase A2--a mediator between proximal and distal effectors of inflammation.

  1991cited by this paper
• Interfacial catalysis by phospholipase A2: dissociation constants for calcium, substrate, products, and competitive inhibitors.

  1991cited by this paper
• Active-site-directed specific competitive inhibitors of phospholipase A2: novel transition-state analogues.

  1991cited by this paper
• Two-step inactivation of bee venom phospholipase A2 by scalaradial.

  1991cited by this paper
• Conversion of pig pancreas phospholipase A2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein.

  1991cited by this paper
• Phospholipase A2 at the bilayer interface

  1991cited by this paper
• Properties of phospholipase A2 isolated from rat serum.

  1991cited by this paper
• Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation.

  1991cited by this paper
• Regulation of CTP:phosphocholine cytidylyltransferase by lipids. 1. Negative surface charge dependence for activation.

  1991cited by this paper
• Interfacial catalysis by phospholipase A2: monomeric enzyme is fully catalytically active at the bilayer interface.

  1991cited by this paper
• Activities of native and tyrosine-69 mutant phospholipases A2 on phospholipid analogues. A reevaluation of the minimal substrate requirements.

  1990cited by this paper
• X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor

  1990cited by this paper
• Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms

  1990cited by this paper
• Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue.

  1990cited by this paper
• Studies on the acyl-chain selectivity of cellular phospholipases A2.

  1990cited by this paper
• Interfacial catalysis: the mechanism of phospholipase A2

  1990cited by this paper
• Activation of phospholipase A2 in rheumatoid arthritis.

  1990cited by this paper
• Activation, aggregation, inhibition and the mechanism of phospholipase A2.

  1990cited by this paper
• The interaction of phospholipase A2 with phospholipid analogues and inhibitors.

  1990cited by this paper
• Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate.

  1990cited by this paper
• Hydrolytic action of phospholipase A2 in monolayers in the phase transition region: direct observation of enzyme domain formation using fluorescence microscopy.

  1990cited by this paper
• Phospholipase A2 and lipocortin effects.

  1990cited by this paper
• Comparative anatomy of phospholipase A2 structures.

  1990cited by this paper
• Function of the fully conserved residues Asp99, Tyr52 and Tyr73 in phospholipase A2.

  1990cited by this paper
• Probing the mechanism of pancreatic phospholipase A2 with the aid of recombinant DNA techniques.

  1990cited by this paper
• Kinetic and inhibition studies of phospholipase A2 with short-chain substrates and inhibitors.

  1990cited by this paper
• Phospholipase A2 in articular cartilage.

  1990cited by this paper
• Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue

  1990cited by this paper
• Soluble phospholipase A2 in human pathology: clinical-laboratory interface.

  1990cited by this paper
• Suicide-inhibitory bifunctionally linked substrates (SIBLINKS) as phospholipase A2 inhibitors. Mechanistic implications.

  1990cited by this paper

• Dehydrodieugenol Neolignans as Multitarget Anti-Inflammatory Agents: sPLA2 Inhibition and Therapeutic Implications

  2026cites this paper
• Phospholipase A2—A Significant Bio-Active Molecule in Honeybee (Apis mellifera L.) Venom

  2025cites this paper
• Regulatory mechanisms triggered by enzyme interactions with lipid membrane surfaces

  2023cites this paper
• The lipid transporter Mfsd2a maintains pulmonary surfactant homeostasis

  2022cites this paper
• Membrane Association Allosterically Regulates Phospholipase A2 Enzymes and Their Specificity

  2022cites this paper
• Understanding the binding mechanism of succinic acid against phospholipase A2 from bee venom

  2021cites this paper
• Deletion mutant of sPLA2 using CRISPR/Cas9 exhibits immunosuppression, developmental retardation, and failure of oocyte development in legume pod borer, Maruca vitrata.

  2020cites this paper
• Synergy between 15-lipoxygenase and secreted PLA2 promotes inflammation by formation of TLR4 agonists from extracellular vesicles

  2020cites this paper
• Quantum Dot Lipase Biosensor Utilizing a Custom-Synthesized Peptidyl-Ester Substrate.

  2020cites this paper
• sPLA2 behaves like a prophylactic agent and mediates cellular and humoral immune responses in Plutella xylostella.

  2020cites this paper
• Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

  2020cites this paper
• Role of Phospholipases A2 as Anti-Covid 19

  2020cites this paper
• Anti-inflammatory and Antidote Drug Discovery with Secreted Phospholipase A2

  2019cites this paper
• Elucidation of lid open and orientation of lipase activated in interfacial activation by amphiphilic environment.

  2018cites this paper
• A non‐venomous sPLA2 of a lepidopteran insect: Its physiological functions in development and immunity

  2018cites this paper
• Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects

  2018cites this paper
• Search and Subvert: Minimalist Bacterial Phosphatidylinositol-Specific Phospholipase C Enzymes.

  2018cites this paper
• Interfacial activation of M37 lipase: A multi-scale simulation study

  2017cites this paper
• The binding of activated Gαq to phospholipase C-β exhibits anomalous affinity

  2017cites this paper
• IR spectroscopy analysis of pancreatic lipase-related protein 2 interaction with phospholipids: 2. Discriminative recognition of various micellar systems and characterization of PLRP2-DPPC-bile salt complexes.

  2017cites this paper
• Factors Regulating the Substrate Specificity of A-type Phospholipases - A Mass-Spectrometric study

  2016cites this paper
• Interfacial enzymes and their interactions with surfaces: Molecular simulation studies

  2016cites this paper
• Prostaglandin regulation of immune responses against coronavirus infections

  2016cites this paper
• Chapter 8 – Phospholipid Catabolism

  2016cites this paper
• Synthesis, Antiphospholipase A2, Antiprotease, Antibacterial Evaluation and Molecular Docking Analysis of Certain Novel Hydrazones

  2016cites this paper
• Specific binding at the cellulose binding module-cellulose interface observed by force spectroscopy.

  2015cites this paper
• Cholesterol oxidase: Role in biotransformation of cholesterol

  2015cites this paper
• A novel calcium-independent cellular PLA2 acts in insect immunity and larval growth.

  2015cites this paper
• Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome–CoV infection

  2015cites this paper
• Substrate Efflux Propensity Is the Key Determinant of Ca2+-independent Phospholipase A-β (iPLAβ)-mediated Glycerophospholipid Hydrolysis*

  2015cites this paper
• Renaturation and one step purification of the chicken GIIA secreted phospholipase A2 from inclusion bodies.

  2014cites this paper
• Modulated mechanism of phosphatidylserine on the catalytic activity of Naja naja atra phospholipase A2 and Notechis scutatus scutatus notexin.

  2014cites this paper
• Enzyme-catalyzed hydrolysis of the supported phospholipid bilayers studied by atomic force microscopy.

  2013cites this paper
• Renaturation and one step purification of the chicken GIIA secreted phospholipase A2 from inclusion bodies.

  2013cites this paper
• A model for the interfacial kinetics of phospholipase D activity on long-chain lipids.

  2013cites this paper
• Stochastic theory of interfacial enzyme kinetics: A kinetic Monte Carlo study

  2012cites this paper
• Quercetin modulates activities of Taiwan cobra phospholipase A2 via its effects on membrane structure and membrane-bound mode of phospholipase A2

  2012cites this paper
• A quantitative continuous enzyme assay of intramolecularly quenched fluorogenic phospholipase substrates for molecular imaging.

  2012cites this paper
• Savinase action on bovine serum albumin (BSA) monolayers demonstrated with measurements at the air-water interface and liquid Atomic Force Microscopy (AFM) imaging.

  2011cites this paper
• Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis

  2011cites this paper
• Novel phospholipases A of Pseudomonas aeruginosa: biochemical characterisation and cellular localisation

  2011cites this paper
• Molecular Docking and 3D-QSAR CoMFA Studies on Indole Inhibitors of GIIA Secreted Phospholipase A2

  2010cites this paper
• Favored reaction mechanism of calcium-dependent phospholipase A(2). Insights from density functional exploration.

  2010cites this paper
• Interfacial binding dynamics of bee venom phospholipase A2 investigated by dynamic light scattering and quartz crystal microbalance.

  2010cites this paper
• 11. Substrate Recognition

  2010cites this paper
• Polyunsaturated fatty acids in the modulation of T-cell signalling.

  2010cites this paper
• Cholesterol oxidase: structure and function.

  2010cites this paper
• Phospholipase A 2 structure/function, mechanism, and signaling 1

  2009cites this paper
• Near-infrared enzyme-activated fluorescent phospholipids for molecular imaging

  2009cites this paper
• Electrodes modified with lipid membranes to study quinone oxidoreductases.

  2009cites this paper
• Snake venom phospholipase A2 enzymes.

  2009cites this paper
• Sequence of physical changes to the cell membrane during glucocorticoid-induced apoptosis in S49 lymphoma cells.

  2009cites this paper
• Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

  2008cites this paper
• Investigating and Modeling Possible Mechanisms by Which Healthy Cell Membranes Become Resistant to Hydrolysis by Secretory Phospholipase A2

  2008cites this paper
• Mechanisms by Which Apoptotic Membranes Become Susceptible to Secretory Phospholipase A2

  2008cites this paper
• Dynamics and Cleavability at the alpha-cleavage site of APP(684-726) in different lipid environments.

  2008cites this paper
• Effects of cholesterol on physical properties of human erythrocyte membranes: impact on susceptibility to hydrolysis by secretory phospholipase A2.

  2008cites this paper
• The structural and functional contribution of N‐terminal region and His‐47 on Taiwan cobra phospholipase A2

  2008cites this paper
• Biochemistry and physiology of mammalian secreted phospholipases A2.

  2008cites this paper
• p38 MAPK activation and mitochondrial depolarization mediate the cytotoxicity of Taiwan cobra phospholipase A2 on human neuroblastoma SK-N-SH cells.

  2008cites this paper
• Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion

  2008cites this paper
• Crystallization and preliminary X-ray crystallographic analysis of the heterodimeric crotoxin complex and the isolated subunits crotapotin and phospholipase A2.

  2007influential citation
• EVOLUTIONARY REDUCTION OF ENZYMATIC ACTIVITIES OF SNAKE VENOM PHOSPHOLIPASES A2

  2007influential citation
• How Escherichia coli Is Equipped to Oxidize Hydrogen under Different Redox Conditions*

  2007cites this paper
• Relationship between membrane physical properties and secretory phospholipase A2 hydrolysis kinetics in S49 cells during ionophore-induced apoptosis.

  2007cites this paper
• The acylation of lipophilic alcohols by lysosomal phospholipase A2 Published, JLR Papers in Press, July 12, 2007.

  2007cites this paper
• Atomic force microscope visualization of lipid bilayer degradation due to action of phospholipase A2 and Humicola lanuginosa lipase.

  2007cites this paper
• Hydrolysis characterization of phospholipid monolayers catalyzed by different phospholipases at the air-water interface.

  2007cites this paper
• Structural biology of recombinant bovine pancreatic phospholipase A2 and its inhibitor complexes.

  2007cites this paper
• Diffusion influence on Michaelis–Menten kinetics: II. The low substrate concentration limit

  2007cites this paper
• Structural elements of ligand recognition site in secretory phospho-lipase A2 and structure-based design of specific inhibitors.

  2007cites this paper
• Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.

  2006cites this paper
• Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti‐inflammatory agents, anisic acid, and atropine reveal a similar mode of binding

  2006cites this paper
• Optically trapping confocal Raman microscopy of individual lipid vesicles: kinetics of phospholipase A(2)-catalyzed hydrolysis of phospholipids in the membrane bilayer.

  2006cites this paper
• Signal transduction in lower esophageal sphincter circular muscle

  2006cites this paper
• Activation of human inflammatory cells by secreted phospholipases A2.

  2006cites this paper
• A new hat for an old enzyme: waste management.

  2006cites this paper
• Crystal structure of a novel phospholipase A2 from crude venom of Indian cobra sub-species Naja naja sagittifera at 1.48 angstoms resolution.

  2005cites this paper
• Crystal structure of a calcium‐induced dimer of two isoforms of cobra phospholipase A2 at 1.6 Å resolution

  2005cites this paper
• Raman spectroscopy of supported lipid bilayers and membrane proteins

  2005cites this paper
• Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2.

  2005cites this paper
• Phospholipases A2: structure and function

  2005cites this paper
• Non-steroidal anti-inflammatory drugs as potent inhibitors of phospholipase A2: structure of the complex of phospholipase A2 with niflumic acid at 2.5 Angstroms resolution.

  2005cites this paper
• Phospholipase D and its application in biocatalysis

  2005cites this paper
• Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to ApcMin/+ tumorigenesis

  2005influential citation
• Signal-transduction pathways that regulate smooth muscle function I. Signal transduction in phasic (esophageal) and tonic (gastroesophageal sphincter) smooth muscles.

  2005cites this paper
• Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.

  2004cites this paper
• [Secreted phospholipases A2 (sPLA2): friends or foes? Are they actors in antibacterial and anti-HIV resistance?].

  2004cites this paper
• Surface pressure dependence of phospholipase A2 activity in lipid monolayers is linked to interfacial water activity.

  2004cites this paper
• Fosfolipasas A2 segregadas (sPLA2):¿amigas o enemigas? ¿Actores de la resistencia antibacteriana y antivirus de la inmunodeficiencia humana?

  2004cites this paper
• Group V sPLA 2 Hydrolysis of Low-Density Lipoprotein Results in Spontaneous Particle Aggregation and Promotes Macrophage Foam Cell Formation

  2004cites this paper
• The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.

  2004cites this paper
• Lipid dependence and activity control of phosphatidylserine synthase from Escherichia coli

  2004cites this paper
• Role of nitric oxide in myotoxic activity induced by crotoxin in vivo.

  2004cites this paper
• Group V sPLA2 Hydrolysis of Low-Density Lipoprotein Results in Spontaneous Particle Aggregation and Promotes Macrophage Foam Cell Formation

  2004cites this paper
• Interfacial binding of bee venom secreted phospholipase A2 to membranes occurs predominantly by a nonelectrostatic mechanism.

  2004cites this paper
• Interfacial Enzymology of Parvovirus Phospholipases A2*

  2004cites this paper
• Cholesterol oxidase senses subtle changes in lipid bilayer structure.

  2004cites this paper
• Molecular characterization of a gene encoding the Drosophila melanogaster phospholipase A2.

  2003cites this paper
• Atomic resolution structure of prokaryotic phospholipase A2: Analysis of internal motion and implication for a catalytic mechanism

  2003cites this paper